相关实验视频

Updated: Jul 28, 2025

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on: June 21, 2024

治疗术后恶心和吐的电针刺激的有效性和安全性:系统性审查和元分析

Liyue Lu¹, Chenlong Xie¹, Xing Li²

¹Department of Anesthesiology & Research Institute of Acupuncture Anesthesia, Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, Shanghai, China.

|May 31, 2023

概括

电针点刺激有效地减少了手术后的恶心和吐 (PONV) 以及对抗的救援药物的需求. 这种方法显示出作为一种安全有效的干预措施,用于管理常见的术后并发症.

科学领域:

麻醉学麻醉学
综合医学是一个整体的医学.
手术并发症手术并发症

背景情况:

手术后恶心和吐 (PONV) 是手术后的常见并发症.
目前用于PONV的药理疗法只能提供部分有效性.
需要对PONV.进行替代和有效的管理策略.

研究的目的:

系统地评估电针点刺激用于管理PONV的疗效和安全性.
评估支持PONV治疗中电针点刺激的证据质量.
为了比较电针点刺激与PONV的标准护理.

主要方法:

进行了全面的元分析.
在主要数据库中进行了搜索,包括PubMed,Embase,Cochrane图书馆,科学网和临床试验.gov.gov.
这项分析包括了26项涉及2064名患者的研究.

主要成果:

与对照治疗相比,电针点刺激显著降低了PONV,恶心和吐的发生率.
它还降低了对抗的救援药物的需求.
电针和穿皮电针点刺激都表现出显著的效果,无论施用时间 (术前,术后或术后).
两组之间没有观察到不良事件的显著差异.

结论:

电针点刺激可能有效地减少PONV发病率和救援抗药的需要.
这种干预措施似乎具有有利的安全性,并很少出现不良事件.
中等到低质量的证据支持这些发现,建议进一步研究.

更多相关视频

Author Spotlight: Alleviating Nausea and Vomiting in Pregnancy with Safe and Effective Auricular Acupuncture

Author Spotlight: Alleviating Nausea and Vomiting in Pregnancy with Safe and Effective Auricular Acupuncture

Published on: August 4, 2023

Effects of Different Connection Modes of Electroacupuncture on Electrocardiogram and Nerve Discharge in Rats

Effects of Different Connection Modes of Electroacupuncture on Electrocardiogram and Nerve Discharge in Rats

Published on: January 3, 2025

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...